I agree that this site is using cookies. You can find further informations here.
X
Kühler, Thomas C.
51  results:
Search for persons X
?
1

Real-world Data and Evidence to support a switch in status ..:

Kühler, Thomas C. ; Ateka, Aritz ; Lassoued, Zeineb..
Clinical Therapeutics.  46 (2024)  3 - p. 208-216 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Rolling Reviews During COVID-19: The European Union Experie..:

Marinus, Roelie ; Mofid, Sarah ; Mpandzou, Marya.
Clinical Therapeutics.  44 (2022)  3 - p. 352-363 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Development and Regulation of Connected Combined Products: ..:

Kühler, Thomas C. ; Schoenmakers, Marc ; Shergold, Oliver...
Clinical Therapeutics.  44 (2022)  5 - p. 768-782 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Dynamic Regulatory Assessment: evolving the European Regula..:

Herrero-Martinez, Esteban ; Hussain, Nasir ; Roux, Nadege Le...
Clinical Therapeutics.  44 (2022)  1 - p. 132-138 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Real-World Data in the Postapproval Setting as Applied by t..:

Mofid, Sarah ; Bolislis, Winona Rei ; Kühler, Thomas C.
Clinical Therapeutics.  44 (2022)  2 - p. 306-322 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Optimizing Pediatric Medicine Developments in the European ..:

Rei Bolislis, Winona ; Bejeuhr, Gesine ; Benzaghou, Fawzi...
Clinical Pharmacology & Therapeutics.  110 (2021)  4 - p. 871-879 , 2021
Link: https://doi.org/10.1002/..
 
?
7

Transparency in European Medicines Agency and US Food and D..:

Bujar, Magda ; Ferragu, Sara ; McAuslane, Neil..
Clinical Therapeutics.  43 (2021)  5 - p. 888-905 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Regulatory Agilities in the Time of COVID-19: Overview, Tre..:

Bolislis, Winona Rei ; de Lucia, Maria Lucia ; Dolz, Felipe...
Clinical Therapeutics.  43 (2021)  1 - p. 124-139 , 2021
Link: https://doi.org/10.1016/..
 
?
9

The Utility of Remote Inspections During the COVID-19 Healt..:

Mofid, Sarah ; Bolislis, Winona Rei ; Brading, Clive...
Clinical Therapeutics.  43 (2021)  12 - p. 2046-2063 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Use of Real-world Data for New Drug Applications and Line E..:

Bolislis, Winona R. ; Fay, Myriam ; Kühler, Thomas C.
Clinical Therapeutics.  42 (2020)  5 - p. 926-938 , 2020
Link: https://doi.org/10.1016/..
 
?
11

From Print to Screen: Regulatory Considerations to Adopting..:

Bolislis, Winona Rei R. ; Mortazavi, Charlie ; Riccioni, Rossana..
Therapeutic Innovation & Regulatory Science.  54 (2019)  4 - p. 831-838 , 2019
Link: https://doi.org/10.1007/..
 
?
12

Orphan Medicines for Pediatric Use: A Focus on the European..:

Bolislis, Winona Rei ; Corriol-Rohou, Solange ; Hill-Venning, Claire...
Clinical Therapeutics.  41 (2019)  12 - p. 2630-2642 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Do Biological Medicinal Products Pose a Risk to the Environ..:

Kühler, Thomas C. ; Andersson, Mikael ; Carlin, Gunnar..
Drug Safety.  32 (2009)  11 - p. 995-1000 , 2009
Link: https://doi.org/10.2165/..
 
?
14

Novel Structures Derived from 2-[[(2-Pyridyl)methyl]thio]-1..:

Carcanague, Daniel ; Shue, Youe-Kong ; Wuonola, Mark A....
Journal of Medicinal Chemistry.  45 (2002)  19 - p. 4300-4309 , 2002
Link: https://doi.org/10.1021/..
 
?
15

Novel Structures Derived from 2-[[(2-Pyridyl)methyl]thio]-1..:

Kühler, Thomas C. ; Swanson, Marianne ; Christenson, Beritte...
Journal of Medicinal Chemistry.  45 (2002)  19 - p. 4282-4299 , 2002
Link: https://doi.org/10.1021/..
 
1-15